Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.95 USD | +4.53% | +13.10% | +86.27% |
05-06 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
04-10 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+86.27% | 13.51M | |
+8.38% | 114B | |
+10.13% | 104B | |
-11.69% | 22.5B | |
+1.14% | 22.57B | |
-11.07% | 17.95B | |
-41.90% | 16.48B | |
-16.00% | 15.82B | |
+2.28% | 13.55B | |
+20.54% | 10.99B |
- Stock Market
- Equities
- CMMB Stock
- News Chemomab Therapeutics Ltd.
- Chemomab Therapeutics Ltd. Names Donald R. Marvin as Chief Financial Officer